10 must read papers from the last year
We are celebrating our first-year anniversary! We hope you have enjoyed our blog thus far. To celebrate we thought we would highlight ten (18 but […]
Five Minutes With: Dr Silvia Franceschi
Our “Five Minutes With” series seeks to discover what are the habits, inspirations and obstacles that have shaped the careers of leading cancer researchers and […]
Why don’t women receive invitations to cervical screening after they turn 65?
Women around the world attend cervical screening regularly during most of their adult life, but in most countries, they are not encouraged to continue once […]
Managing women’s cancers in Lynch syndrome
In this post Dr Emma Crosbie, Senior Lecturer & Honorary Consultant Gynaecological Oncologist, tells us about the first ever workshop to develop international standards of […]
Five Minutes With: Professor Julietta Patnick CBE
Our “Five Minutes With” series seeks to discover what are the habits, inspirations and obstacles that have shaped the careers of leading cancer researchers and […]
Screening iconoclasm series: Is it time for cancer screening to become non-binary?
In our final iconoclasm series post, Peter Sasieni explores the merits of making cancer screening non-binary. The classic paradigm for diagnostic testing and medical screening […]
Screening iconoclasm series: Could you be more specific about what you mean by specificity?
In this post, Peter Sasieni argues that it is time to be more specific about our definitions of specificity and false positive tests. How will […]
Five Minutes With: Professor Willie Hamilton CBE
Our “Five Minutes With” series seeks to discover what are the habits, inspirations and obstacles that have shaped the careers of leading cancer researchers and […]
Post-Brexit Deregulation Risks Asbestos Crisis
Post written by Rosie Rosati, Health Advocate Both the amount of asbestos in UK lungs and the UK mesothelioma rate below age 50 are declining […]
Screening iconoclasm series: Are you putting too much value on positive predictive value?
If you read the previous blog from the screening iconoclast and know a little about screening, you might be thinking that the thing to do […]